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ABSTRACT
Objectives:
A new device that combines, for the first time, two photonic technologies (time-resolved near-infrared 
spectroscopy and diffuse-correlation spectroscopy), was provided and tested within the BabyLux 
project. Aim was to validate the expected changes in cerebral oxygenation and blood flow. 
Methods:
A pulse oximeter and the BabyLux device were held in place (right hand/wrist and fronto-parietal 
region, respectively) for 10 minutes after birth in healthy term infants delivered by elective cesarean 
section. Pulse oximeter saturation(SpO2), cerebral tissue oxygen saturation(StO2) and blood flow 
index(BFI) were measured over time. Tissue oxygen extraction(TOE) and cerebral metabolic rate of 
oxygen index(CMRO2I) were calculated. 
Results:
Thirty infants were enrolled in two centers. After validity check of data, 23% of infants were excluded 
from TOE and CMRO2I calculation due to missing data. As expected, SpO2 (estimate 3.05 %/min; 
CI: 2.78, 3.31 %/min) and StO2 (estimate 3.95 %/min; CI: 3.63, 4.27 %/min) increased in the first 10 
min after birth, whereas BFI (estimate -2.84·10-9 cm2/s/min; CI: -2.50·10-9, -3.24·10-9 cm2/s/min) and 
TOE (estimate -0.78%/min; CI: -1.12, -0.45 %/min) decreased. Surprisingly, CMRO2I decreased 
(estimate -7.94 ·10-8/min; CI: -6.26·10-8, -9.62·10-8 /min).
Conclusions:
Brain oxygenation and BFI during transition were successfully and simultaneously obtained by the 
BabyLux device; no adverse effects were recorded and the BabyLux device didn’t limit the standard 
care.   
The preliminary results from clinical application of the BabyLux device are encouraging in terms of 
safety and feasibility; they are consistent with previous reports on brain oxygenation during transition  
although the interpretation of the decreasing CMRO2I remains open.
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KEY WORDS:
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ABBREVIATIONS: 
Absorption coefficient (μ a), arterial oxygen saturation (SaO2), venous oxygen saturation (SvO2), 
blood flow index (BFI), cerebral metabolic rate of oxygen index (CMRO2I), concentration of oxy-
haemoglobin (O2Hb), concentration of deoxy-haemoglobin (HHb), diffuse correlation spectroscopy 
(DCS), distribution of time-of-flight (DTOF), near-infrared spectroscopy (NIRS), tissue oxygen 
extraction (TOE), pulse oxygen saturation (SpO2), reduced scattering coefficient (μs’), time-resolved 
spectroscopy (TRS), tissue oxygen saturation (StO2).
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INTRODUCTION:
During the last decades, progress in neonatal medicine has led to an increased survival rate of preterm 
infants. Despite this, the risk of brain damage and later neurodevelopmental deficits is still high and 
the understanding of the underlying pathophysiological mechanisms is nevertheless incomplete.[1,2] 
Different perinatal factors (hemodynamics, oxygen metabolism, infection-inflammation) are 
involved in the pathogenesis of brain damage. A more accurate identification of the leading 
mechanisms on a single-patient basis is desirable to provide individualized care and targeted 
intervention aimed to safeguard the developing brain.
The most vulnerable period is represented by the first hours and days after birth due to the risk of 
haemodynamic disturbances occurring during the transitional circulation combined with the impact 
of respiratory distress syndrome. Furthermore, critically ill premature infants have impaired cerebral 
autoregulation, which may expose them to both hyperoxic and hypoxic insults, both involved in brain 
injury.[3,4]
To that end, a continuous and non-invasive monitoring of cerebral perfusion and oxygenation has 
been searched for.[5]
Commercially available near-infrared spectroscopy (NIRS) devices are currently used in clinical care 
and in clinical trials as cerebral oximeters.[6,7] Interpretation of cerebral oxygenation as a surrogate 
measure of cerebral blood flow, however, depends on the assumption of stable oxygen consumption. 
This is relevant for instance when using NIRS to estimate cerebral autoregulation capacity or when 
used clinically as an indication for interventions to increase blood flow. Alternatively cerebral 
oxygenation may be affected by change in oxygen demand. The BabyLux project aimed to provide a 
non-invasive and cot-side device, that combines time-resolved NIRS (TRS), for calculation of 
regional oxygenation, with newly developed diffuse correlation spectroscopy (DCS), for calculation 
of regional perfusion, in an attempt to resolve this ambiguity.
TRS measures the attenuation, delay, and the temporal broadening of relatively short light pulses 
(pulse duration ~100 ps) that has passed through a diffusive medium. TRS thus has the ability to 
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resolve path-lengths of photons and to separate the absorption and scattering coefficients allowing 
for measurements of tissue oxygen saturation (StO2).[8]  DCS studies the statistics of the diffuse coherent light into the tissue. The fluctuations of the intensity 
measured at the surface of the tissue are affected by the movement of the moving scatterers, mainly 
the red blood cells. Studying the statistics of these fluctuations allows for the quantification of the so-
called blood flow index BFI, a quantity proportional to the microvascular blood flow.[9,10] 
This innovative combined technology allows the calculation of cerebral metabolic rate of oxygen and, 
to our knowledge, only few studies have been published on this topic using combined multi-distance 
frequency domain NIRS and DCS.[11,12]
As direct validation of cerebral oxygenation and blood flow against a ‘gold standard’ is not feasible 
in newborn infants, we performed measurements in a clinical situation in which changes in cerebral 
oxygenation and brain perfusion occur and have been previously described. The aim was to obtain 
“expected results” according to the available evidence. We studied the postnatal transition of healthy 
term infants delivered by elective, uncomplicated caesarian section; in this situation, cerebral tissue 
oxygenation is expected to be lower than arterial saturation at all time-points, progressively rising 
and reaching a plateau within the first 10 minutes after birth. Moreover, small-to-moderate changes 
in cerebral blood flow, small changes in oxygen extraction, and no change in oxygen consumption 
are expected given the observations of lower cord cortisol and catecholamines levels after elective 
cesarean delivery compared to vaginal delivery. [13-15]
The BabyLux device provides a simultaneous measurement of regional oxygenation and perfusion 
and allows to disentangle the interplay between oxygen demand and perfusion, resolving the 
ambiguity in the interpretation of changes in regional saturation.
Aim:
The aim of this study was to validate the BabyLux device by simultaneously measuring the expected 
changes in cerebral oxygenation and blood flow and by calculating the cerebral oxygen metabolism.
METHODS:
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Study protocol:
The study was conducted according to ISO 14155:2011 with external monitoring. Local research 
ethics committees approved the same study protocol in both centers (Rigshospitalet, Copenhagen, 
Denmark and Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy). The 
protocol is registered at ClinicalTrials.gov, identifier NCT02815618.
Inclusion criteria were: gestational age more than 37 weeks and planned delivery by uncomplicated 
elective cesarean section. Exclusion criteria were: congenital malformation apparent at birth with 
need for any additional assistance immediately following delivery and need for resuscitation or 
supplementary oxygen during the first 10 minutes after birth. 
Parental consent was obtained before elective caesarean section. 
The BabyLux device and the pulse oximeter (Radical 7; Masimo Corporation, Irvine, CA, U.S.A.) 
were both synchronized with the local clock time of the delivery room. 
After birth the infant was immediately wrapped in warm towels and the head and right hand or wrist 
were cleaned to remove vernix and amniotic fluid (which could affect probe contact and signal 
quality). As soon as possible, the BabyLux probe was positioned in the fronto-parietal region of the 
newborn’s head to measure StO2 and BFI, and the pulse oximeter probe was placed on the right hand 
or wrist to measure pulse oxygen saturation (SpO2) and pulse rate. Both probes were held in place by 
self-adhesive elastic bandage. For both instruments measurements lasted for at least 10 min, while 
standard neonatal care was given. According to international guidelines [16] we considered standard 
neonatal care: to warm and maintain normal temperature, to position the head in “sniffing” position, 
to clear secretion if needed, and to dry. If resuscitation was performed (from tactile stimulation 
onwards), according to our methods, the infant was excluded from the study.
In both centers timing of cord clamping was between 30 and 60 sec.
The following parameters were finally recorded over time by 10 s bins: SpO2, pulse rate, StO2, BFI.
Tissue oxygen extraction (TOE) was calculated as TOE=SpO2-StO2, and the cerebral metabolic rate 
of oxygen index (CMRO2I) was calculated as CMRO2I=TOE·BFI
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Neonatal characteristics (gestational age, birth weight, sex, Apgar score) were collected.
Instrumentation:
Two identical prototypes were built within the project and they were approved for research use 
according to the clinical investigation plan by the national Medical Device Agencies in both countries. 
The BabyLux device integrates TRS and DCS modules similar to those previously described by 
Torricelli et al.[8] and Durduran et al.[9], respectively. In brief, the TRS module employs pulsed 
lasers operating at three different wavelengths centered at about 685 nm, 760 nm, and 820 nm, 
respectively. The pulse duration is <100 ps, with a repetition rate of 20 MHz, and an average output 
power <1 mW for all wavelengths. A photomultiplier and a time-correlated single photon counting 
board are used to acquire the distribution of photon time of flight (DTOF) for each wavelength. The 
DCS module uses a continuous wave long coherence laser at 785 nm with an output power < 20 mW. 
Two single avalanche photodiodes and a custom-made correlator unit are used to acquire the 
autocorrelation of the measured light intensity. TRS and DCS share a compact and light weight fiber-
optic probe, for injection and collection of the light signals into the tissue. TRS and DCS source-
detector separation is 15 mm. 
We have carefully evaluated the safety risk associated with the use of the pulsed laser (TRS) and 
continuous wave laser (DCS) according to the standard IEC 60825-1:2007. Regarding the effect on 
skin, for both lasers the emitting power is lower than the maximum permissible exposure (MPE) by 
an order of magnitude. However, as an additional precaution for heat dissipation, the DCS laser is 
switched off for 1 second every 9 seconds. For the effect on eye, the pulsed lasers are safe for the 
operator because time exposure to the laser light is shorter (0.25 s) due to the blink reflex. Conversely, 
for infants we can not rely on the blink reflex and/or ocular movement, therefore we cannot consider 
the pulsed lasers eye safe for the accidental exposure to laser light. The same happens for the DCS 
laser. In order to ensure safe operation of the device, proper measure of protection (i.e. a mask 
covering the eyes like the mask used for phototherapy) was used together with a capacitive sensor 
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designed to detect skin contact which is integrated in the probe head. These procedures were approved 
by the ethical committees and by the national medical device agencies in Italy and Denmark.
A detailed description of the BabyLux system is available in Giovannella et al.[17]
Data processing and quality assessment: 
Processing of TRS data consists of estimating the optical properties (absorption coefficient, µa, and 
reduced scattering coefficient, µs’) at all wavelengths, then calculating the hemodynamic parameters 
(concentration of oxy-haemoglobin, O2Hb, and deoxy-haemoglobin, HHb), and finally evaluating the 
quality of results. 
For the estimation of the optical properties, the DTOF is fitted with a model for photon diffusion in 
a semi-infinite homogeneous medium, after convolution with the instrument response function. The 
fitting procedure is described in Cubeddu et al.[18] 
Once the estimates of µa at the three wavelengths are obtained, O2Hb and HHb are calculated by 
means of Beer’s law. Specific absorption values for hemoglobin are taken from the Prahl dataset.[19] 
Lipid content in neonates is limited and therefore disregarded, while water content is fixed at 
90%.[20] 
From O2Hb and HHb values we obtained the total haemoglobin content tHb=O2Hb+HHb, and 
StO2=100 O2Hb/tHb.
The main factor affecting the quality of TRS data is the number of photon in the DTOF(N). A 
minimum value of N>103 was used as threshold. The quality of fitting was evaluated through the 
reduced chi-square χ 2 parameter. Large values (χ 2>10) and very low values (χ 2<0.1) were 
discarded since they can be indicative of poor fitting model or signal-to-noise ratio, respectively. 
Further criteria were set on the values for µs’ and on the values for StO2. Given the assumption of 
photon diffusion (as a rule of thumb, µs’>> µa), if at any wavelength the fitting provides too low 
values for µs’ (e.g. µs’<1 cm-1), then there is the possibility that the use of the photon diffusion model 
is inappropriate and values were therefore excluded. 
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The normalized intensity field autocorrelation curve acquired in DCS measurements is fitted to the 
solution of the diffusion equation for the autocorrelation function for the semi-infinite homogeneous 
geometry. As the source detector separation is known and the optical properties have been estimated 
by TRS at 760 nm, they can be inserted in the model, enabling determination of BFI. DCS curves 
acquired with an intensity rate below 10 kHz were excluded, due to poor signal-to-noise ratio. Results 
with residuals higher than 2 SD from the mean were rejected. 
For the calculation of BFI, 10 s moving average of µa at 760 nm was used to reduce noise propagation 
from TRS to DCS analysis  and a fixed sample average estimate of µs’ was used (µs’=7 cm-1); BFI 
and µs’ are indeed coupled in the equation describing the intensity field autocorrelation curve [21] 
and an eventual error in the latter is propagated in an error in the BFI [22]. Therefore using an 
individual estimation  of µs’ can increase the inter-individual variability for the BFI.
Statistics:
Descriptive analyses were obtained for the infants’ neonatal characteristics. Continuous variables are 
described as mean (SD) or median (range), while categorical variables are expressed as number and 
percentage.
For SpO2, StO2, BFI, TOE and CMRO2I box-plots were used to show changes over time.
Over the first 10 min after birth the relationship between variables and time was studied using linear 
mixed-effect models with subject as random effect. Models results are expressed as estimate, 95% CI 
along with p-values. Values of p < 0.05 were considered statistically significant. Logarithmic base 10 
transformation of BFI and CMRO2I data was done to normalize the right-skewed distribution of 
residuals.  
From 10 min after birth onward, median value, 25th and 75th percentiles were calculated for each 
variable.
Statistical analyses were performed using R, version 3.4.3 (R Foundation for Statistical Computing, 
Vienna, Austria).
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RESULTS:
Thirty infants were enrolled from October 2016 to April 2017: 14 infants in Copenhagen (CPH) and 
16 in Milan (MI). Four infants were excluded: one requiring resuscitation at birth, two due to parental 
consent withdrawn, and one because of technical reasons (BabyLux software crash). 
Mean (SD) gestational age was 38.4 (0.7) weeks [38.5 (0.8) in CPH and 38.3 (0.6) in MI]; mean (SD) 
birthweight was 3258g (393g) [3299g (438g) in CPH and 3225g (366g) in MI]; male (%) were 13 
(50) [5 (45) in CPH and 8 (53) in MI]; median (range) Apgar 1’ was 10 (8-10) [10 (9-10) in CPH and 
9 (8-9) in MI]; median (range) Apgar 5’ was 10 (9-10) [10 (10) in CPH and 9 (8-9) in MI].
After validity check of data, the final number of accepted measurements were 23 (88.5%) for 
SpO2/pulse rate (10 in CPH and 13 in MI); 23 (88.5%) for TRS (8 in CPH and 15 in MI), 25 (96.2%) 
for DCS (11 in CPH and 14 in MI), 20 (76.9%) for calculated TOE and CMRO2I. 
Figures 1 to 5 show changes of the measured variables from the 3rd min after birth over time. 
Data from birth to the 3rd min are not displayed as very few data-points were collected in that time-
frame: the average starting time for BabyLux measurement was 3.5 min (SD 1.5 min) after birth (see 
details in supplementary material).
We analyzed changes in all parameters until the 10th min after birth: SpO2 significantly increased 
over time, as well as StO2 while BFI and TOE significantly decreased. Surprisingly, a significant 
decrease in CMRO2I was observed.
SpO2 (estimate 3.05 %/min; CI: 2.78, 3.31 %/min; p<0.001) and StO2 (estimate 3.95 %/min; CI: 3.63, 
4.27 %/min; p<0.001) increased in the first 10 min after birth, whereas BFI (estimate -2.84·10-9 
cm2/s/min; CI: -2.50·10-9, -3.24·10-9 cm2/s/min; p<0.001) and TOE (estimate -0.78%/min; CI: -1.12, 
-0.45 %/min; p<0.001) decreased. Also CMRO2I decreased (estimate -7.94 ·10-8/min; CI: -6.26·10-8, 
-9.62·10-8 /min; p<0.001).
From the 10th min onward, median SpO2 (25th -75th percentiles) was 94.8% (92.9%-97.1%), StO2 
65.6% (59.9%-73.3%), BFI 2.50∙10-8 cm2/sec (1.88∙10-8-3.46∙10-8), TOE 29.0% (22.7%-31.4%) and 
CMRO2I 6.09∙10-7 (4.78∙10-7-8.67∙10-7). 
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No adverse effects were recorded during the study period. 
DISCUSSION:
The use of the BabyLux device during the transition period after birth was feasible; it was safe for 
the patients and did not limit the standard care.
The recording start time for the BabyLux device was reasonable: we obtained valid measurements in 
58% of infants by 3 min after birth and in 88% of infants by 5 min. These results are similar to those 
reported by previous studies during transition: Urlesberger et al. measured 50% of infants by 3 min 
[23] using INVOS5100 and Baik et al. 79% of newborns by 3 min with NIRO.[24] Shorter starting 
time are reported by Ziehenberger E. et al, with NIRO or INVOS5100C (mean, 95 sec. and 93 sec, 
respectively) [25], Fauchere et al. with NIRO (median, 2 min; range, 1-4 min),[26] Almaazmi et al. 
with FORESIGHT (median time to signal, 63 s; interquartile range, 38-88 s),[27] and Isobe with 
IMUC7000 (measurement begun at 1-2.5 min).[28]
After validity check of data, 23% of infants were excluded from TOE and CMRO2 calculation due to 
missing data (TRS in 12% and DCS in 4% of case) suggesting that technical issues still need to be 
improved. However, other instruments, as pulse-oximeter, routinely used in clinical practice, showed 
similar performances.
The recorded SpO2 data are in line with the reference values by Dawson et al. for infants born by 
elective cesarean section.[31]
The measured changes in StO2 and BFI are consistent with the previous reports.[23-30,32]
Cerebral StO2 by fronto-parietal TRS sensor followed the rise in SpO2, similarly to previous 
observations performed on the same population using other NIRS techniques.[23-30] Indeed, StO2 
values derived from TRS seem grossly comparable with values obtained by NIRO300,[24-26] FORE-
SIGHT cerebral oximeter,[27] IMUC7000 [28] (although some of these studies censored data points 
where StO2 exceeded SpO2, which we did not do) but lower than values measured by INVOS5100 
with neonatal sensors. [23,25,29,30] This observation is consistent with previous studies reporting 
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significantly higher regional StO2 values when using pediatric and neonatal sensors compared to the 
INVOS5100 adult sensors.[33,34] 
The derived value of TOE decreased over time in the first 10 min after birth, although a high inter-
individual variability was observed. This finding is in line with previous studies that investigated 
changes in fractional tissue oxygen extraction (FTOE) showing a reduction in the first minutes of life, 
although TOE and FTOE cannot be directly compared during the sudden increase in oxygen delivery 
after birth.[23,35]
Cerebral blood flow (expressed as BFI) decreased by 30% over the study time. This result is 
consistent with a 30% decrease in cerebral blood flow velocity, measured by Doppler, previously 
reported in healthy term newborns.[32] This data, however, was obtained after vaginal birth and the 
decrease was observed from 7 to 13 min after birth. Nevertheless, a cerebrovascular response to the 
increase in blood oxygen content at birth is to be expected. 
This is the first study in which DCS was used to measure BFI during transition after birth. BFI is an 
absolute quantification of cerebral blood flow with an unusual unit (cm2/s) that differs from the 
conventionally reported ml/100g/min for blood flow and cm/s for blood flow velocity. However, DCS 
has been broadly qualitatively validated and a few in-vivo calibrations have been reported.[10] Using 
a calibration obtained in young piglets by comparing the BabyLux DCS with CBF measured with positron emission tomography,[38] we calculated that the median BFI value from the 10th minutes 
after birth onward corresponded to 23.3 ml/100g/min.   These results are in line with those expected 
in healthy term infants, taking into consideration the reported coefficient of variability and the small 
number of observations.[39,40]
Furthermore, BFI values measured by the BabyLux device after the 10th min after birth are 
comparable with previously reported BFI values obtained using a combination of frequency domain 
NIRS and DCS systems in healthy newborns admitted to the nursery.[36,37] The BabyLux 
technology offers a unique possibility to obtain direct measurements of cerebral blood flow even in 
such a peculiar situation when no other available technology (PET, SPECT, MRI) could be used. 
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We expected constant CMRO2I values because infants born by uncomplicated cesarean section have 
low levels of catecholamine compared to those vaginally delivered and therefore are not expected to 
be significantly stressed or asphyxiated and therefore not to have developed an oxygen ‘debt’ during 
delivery.[14,15]
Therefore, it was surprising that we found a nearly 50% decrease in CMRO2I, that was highly 
statistically significant, from the first minutes after birth until stabilization at about 10 minutes.
CMRO2I is a measure of oxygen metabolism and thus reflects the infants' cerebral metabolic state. 
Arousal occurring at birth should be associated with higher CMRO2I. Our results therefore may 
suggest that even an uncomplicated cesarean section involve some physical stress and strain and, due 
to the delay in the recording start time in our study, we might have measured the descending curve 
associated with the gradual reduction in the alert state with cerebral activation a few minutes after 
birth. Alternatively, we may speculate that this unexpected result is due to an oxygenation-level 
dependent error of measurement of at least one of involved variables SpO2, StO2 or BFI, and/or an 
oxygenation-level dependent change in the arterio-venous ratio, i.e. the factor that relates StO2 to 
arterial oxygen saturation SaO2 and to venous oxygen saturation SvO2 [41] All of this is really 
possible.  Hence the physiologic interpretation of this finding is open. 
 In conclusion, changes in brain oxygenation and cerebral blood flow during transition were 
successfully and simultaneously measured by the BabyLux device in most infants. The dataset is 
sufficiently large to be robust. The StO2, TOE and BFI values were plausible, although the decrease 
in CMRO2I was unexpected and most likely indicate some oxygenation-level dependent error in one 
or more of the measured variables. 
These preliminary results from the clinical application of the BabyLux device are encouraging in 
terms of reliability, safety, and feasibility. 
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What is already know on this topic:
• A continuous and non-invasive monitoring of cerebral perfusion and oxygenation has been 
searched for better understanding the pathogenesis of brain damage in neonates.
• Time-resolved-near-infrared spectroscopy has the ability to resolve path-lengths of photons 
and to separate the absorption and scattering coefficients allowing for measurements of tissue 
oxygen saturation.
• Diffuse-correlation spectroscopy relies on the interaction between long coherence laser light 
and moving scatterers, allowing for quantification of microvascular blood flow and 
calculation of a blood flow index.
What this study adds: 
• The BabyLux device combines, for the first time, two photonic technologies (TRS/DCS), 
providing a non-invasive, cot-side and c ntinuous monitoring of tissue oxygenation and blood 
flow.
• Cerebral tissue oxygenation and blood flow values obtained by BabyLux in term infants 
during transition after birth, were plausible.
• The cerebral metabolic rate of oxygen that was calculated from this data, decreased 
significantly: this was unexpected and the interpretation remains open.
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Box-plot of SpO2 changes over time. 
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Box-plot of StO2 changes over time. 
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Box-plot of BFI changes over time. 
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Box-plot of TOE changes over time. 
142x80mm (300 x 300 DPI) 
Page 24 of 28
https://mc.manuscriptcentral.com/adc
Archives of Disease in Childhood
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
 
Box-plot of CMRO2I changes over time. 
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Cerebral oxygenation and blood flow in term infants during postnatal transition: BabyLux project.
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Figure 1a: SpO2 by subject
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Figure 2a: StO2 by subject
Figure 3a: BFI by subject
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Figure 4a: TOE by subject
Figure 5a: CMRO2I by subject
Page 28 of 28
https://mc.manuscriptcentral.com/adc
Archives of Disease in Childhood
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
